This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Cataracts/ Lens  • Glaucoma  • Intraocular Lenses  • Ophthalmological Procedures, Other  • Statistics and Research Methods  • Prognosis/ Outcomes  • Alert me on articles by topic  Social Bookmarking   What's this?

Fariba Ghassemi, MD; Carol L. Shields, MD; Melis Palamar, MD; Ralph C. Eagle Jr, MD; Jerry A. Shields, MD

Arch Ophthalmol. 2008;126(8):1166-1168.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The ocular surface is protected by a thin, 3-layered, clear tear film. Systemic and local diseases can affect the content and color of the tear film. Bloody tears (hemolacria [Latin] or hematodacryorrhea [Greek]) are a red discoloration of the tears associated with several conditions, including epistaxis, contact lens irritation, severe anemia, coagulopathies (hemophilia), conjunctival vascular tumors, Osler-Weber-Rendu disease, nasolacrimal sac tumors, and conjunctival melanoma.^1-2 Additionally, some drugs and diagnostic dyes can change the color of bodily secretions such as tears (rifampicin and fluorescein). In this article, we describe a patient with black tears (nigrolacria [Latin] or melanodacryorrhea [Greek]) who was found to have an extensively necrotic uveal melanoma by extraocular extension (EOE).

Report of a Case

A 71-year-old white man experienced painless blurred vision of the left eye for 2 months. During the previous 2 . . . [Full Text of this Article]

Comment

AUTHOR INFORMATION


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?